Timing of operation in asymptomatic severe aortic stenosis

Hari P Chaliki, Morgan L. Brown, Thoralf M. Sundt, A. Jamil Tajik

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Calcific aortic stenosis is now the main cause of aortic stenosis in the majority of patients, due to declining incidence of rheumatic fever. Risk factors such as hyperlipidemia play an important role in the progression of aortic stenosis. According to the most recent American College of Cardiology/American Heart Association guidelines, peak velocity greater than 4 m/sec, a mean gradient of more than 40 mmHg and a valve area of less than 1.0 cm2 is considered hemodynamically severe aortic stenosis. Aortic valve surgery promptly should be done in symptomatic patients due to dismal prognosis without operation. Features such as high aortic valve calcium and positive exercise test identify asymptomatic patients who would benefit from early aortic valve surgery. Due to improvement in surgical techniques and better prosthesis, aortic valve surgery can now be offered at low risk to a selected group of asymptomatic patients with severe aortic stenosis. Currently percutaneous aortic valves are used in very high-risk patients with severe symptomatic aortic stenosis. Their role may expand in the future, depending on the improvements in design and operator experience. Whether advances in molecular cardiology lead to novel therapies in preventing calcific aortic stenosis in the future remains to be seen.

Original languageEnglish (US)
Pages (from-to)1065-1071
Number of pages7
JournalExpert Review of Cardiovascular Therapy
Volume5
Issue number6
DOIs
StatePublished - Nov 2007

Fingerprint

Aortic Valve Stenosis
Aortic Valve
Rheumatic Fever
Hyperlipidemias
Cardiology
Exercise Test
Prostheses and Implants
Guidelines
Calcium
Incidence
Calcification of Aortic Valve

Keywords

  • Aortic stenosis
  • Asymptomatic
  • Epidemiology
  • Statins
  • Surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Timing of operation in asymptomatic severe aortic stenosis. / Chaliki, Hari P; Brown, Morgan L.; Sundt, Thoralf M.; Tajik, A. Jamil.

In: Expert Review of Cardiovascular Therapy, Vol. 5, No. 6, 11.2007, p. 1065-1071.

Research output: Contribution to journalArticle

Chaliki, Hari P ; Brown, Morgan L. ; Sundt, Thoralf M. ; Tajik, A. Jamil. / Timing of operation in asymptomatic severe aortic stenosis. In: Expert Review of Cardiovascular Therapy. 2007 ; Vol. 5, No. 6. pp. 1065-1071.
@article{234ba029cecc4120b2311e3580c2106a,
title = "Timing of operation in asymptomatic severe aortic stenosis",
abstract = "Calcific aortic stenosis is now the main cause of aortic stenosis in the majority of patients, due to declining incidence of rheumatic fever. Risk factors such as hyperlipidemia play an important role in the progression of aortic stenosis. According to the most recent American College of Cardiology/American Heart Association guidelines, peak velocity greater than 4 m/sec, a mean gradient of more than 40 mmHg and a valve area of less than 1.0 cm2 is considered hemodynamically severe aortic stenosis. Aortic valve surgery promptly should be done in symptomatic patients due to dismal prognosis without operation. Features such as high aortic valve calcium and positive exercise test identify asymptomatic patients who would benefit from early aortic valve surgery. Due to improvement in surgical techniques and better prosthesis, aortic valve surgery can now be offered at low risk to a selected group of asymptomatic patients with severe aortic stenosis. Currently percutaneous aortic valves are used in very high-risk patients with severe symptomatic aortic stenosis. Their role may expand in the future, depending on the improvements in design and operator experience. Whether advances in molecular cardiology lead to novel therapies in preventing calcific aortic stenosis in the future remains to be seen.",
keywords = "Aortic stenosis, Asymptomatic, Epidemiology, Statins, Surgery",
author = "Chaliki, {Hari P} and Brown, {Morgan L.} and Sundt, {Thoralf M.} and Tajik, {A. Jamil}",
year = "2007",
month = "11",
doi = "10.1586/14779072.5.6.1065",
language = "English (US)",
volume = "5",
pages = "1065--1071",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Timing of operation in asymptomatic severe aortic stenosis

AU - Chaliki, Hari P

AU - Brown, Morgan L.

AU - Sundt, Thoralf M.

AU - Tajik, A. Jamil

PY - 2007/11

Y1 - 2007/11

N2 - Calcific aortic stenosis is now the main cause of aortic stenosis in the majority of patients, due to declining incidence of rheumatic fever. Risk factors such as hyperlipidemia play an important role in the progression of aortic stenosis. According to the most recent American College of Cardiology/American Heart Association guidelines, peak velocity greater than 4 m/sec, a mean gradient of more than 40 mmHg and a valve area of less than 1.0 cm2 is considered hemodynamically severe aortic stenosis. Aortic valve surgery promptly should be done in symptomatic patients due to dismal prognosis without operation. Features such as high aortic valve calcium and positive exercise test identify asymptomatic patients who would benefit from early aortic valve surgery. Due to improvement in surgical techniques and better prosthesis, aortic valve surgery can now be offered at low risk to a selected group of asymptomatic patients with severe aortic stenosis. Currently percutaneous aortic valves are used in very high-risk patients with severe symptomatic aortic stenosis. Their role may expand in the future, depending on the improvements in design and operator experience. Whether advances in molecular cardiology lead to novel therapies in preventing calcific aortic stenosis in the future remains to be seen.

AB - Calcific aortic stenosis is now the main cause of aortic stenosis in the majority of patients, due to declining incidence of rheumatic fever. Risk factors such as hyperlipidemia play an important role in the progression of aortic stenosis. According to the most recent American College of Cardiology/American Heart Association guidelines, peak velocity greater than 4 m/sec, a mean gradient of more than 40 mmHg and a valve area of less than 1.0 cm2 is considered hemodynamically severe aortic stenosis. Aortic valve surgery promptly should be done in symptomatic patients due to dismal prognosis without operation. Features such as high aortic valve calcium and positive exercise test identify asymptomatic patients who would benefit from early aortic valve surgery. Due to improvement in surgical techniques and better prosthesis, aortic valve surgery can now be offered at low risk to a selected group of asymptomatic patients with severe aortic stenosis. Currently percutaneous aortic valves are used in very high-risk patients with severe symptomatic aortic stenosis. Their role may expand in the future, depending on the improvements in design and operator experience. Whether advances in molecular cardiology lead to novel therapies in preventing calcific aortic stenosis in the future remains to be seen.

KW - Aortic stenosis

KW - Asymptomatic

KW - Epidemiology

KW - Statins

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=37349003386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349003386&partnerID=8YFLogxK

U2 - 10.1586/14779072.5.6.1065

DO - 10.1586/14779072.5.6.1065

M3 - Article

C2 - 18035922

AN - SCOPUS:37349003386

VL - 5

SP - 1065

EP - 1071

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 6

ER -